Senzar Asset Management

Senzar Asset Management as of March 31, 2018

Portfolio Holdings for Senzar Asset Management

Senzar Asset Management holds 31 positions in its portfolio as reported in the March 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
AstraZeneca (AZN) 8.4 $27M 758k 34.97
EXACT Sciences Corporation (EXAS) 6.9 $22M 542k 40.35
Regeneron Pharmaceuticals (REGN) 6.7 $21M 62k 344.35
Sanofi-Aventis SA (SNY) 6.5 $21M 511k 40.08
Mylan Nv 6.4 $20M 494k 41.15
Allergan 4.9 $16M 92k 168.29
Pfizer (PFE) 4.9 $16M 435k 35.49
CIGNA Corporation 4.9 $15M 92k 167.74
Merck & Co (MRK) 4.8 $15M 282k 54.47
Medtronic (MDT) 4.0 $13M 160k 80.22
Alder Biopharmaceuticals 3.3 $11M 823k 12.71
Novartis (NVS) 3.2 $10M 127k 80.85
Amgen (AMGN) 3.2 $10M 59k 170.47
Ironwood Pharmaceuticals (IRWD) 3.2 $10M 650k 15.42
Dr. Reddy's Laboratories (RDY) 3.0 $9.6M 295k 32.66
CVS Caremark Corporation (CVS) 2.4 $7.5M 121k 62.21
Aetna 2.3 $7.4M 44k 168.75
Tg Therapeutics (TGTX) 2.1 $6.8M 476k 14.20
MiMedx (MDXG) 2.0 $6.3M 902k 6.97
Endologix 1.8 $5.6M 1.3M 4.23
United Therapeutics Corporation (UTHR) 1.7 $5.3M 47k 112.22
Bristol Myers Squibb (BMY) 1.6 $5.2M 82k 63.24
NxStage Medical 1.6 $5.2M 209k 24.81
Sientra 1.6 $5.1M 529k 9.66
Arena Pharmaceuticals 1.6 $5.0M 128k 39.50
AmerisourceBergen (COR) 1.6 $5.0M 58k 86.22
Concert Pharmaceuticals I equity 1.4 $4.6M 199k 22.94
Theravance Biopharma (TBPH) 1.4 $4.6M 188k 24.25
Aerie Pharmaceuticals 1.2 $3.8M 71k 54.25
Anaptysbio Inc Common (ANAB) 0.8 $2.6M 25k 104.07
Protagonist Therapeutics (PTGX) 0.5 $1.5M 176k 8.59